These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12946875)

  • 1. Molecular basis of resistance to thyroid hormone.
    Yen PM
    Trends Endocrinol Metab; 2003 Sep; 14(7):327-33. PubMed ID: 12946875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thyroid hormone resistance syndrome].
    Carvalho GA; Ramos HE
    Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):83-92. PubMed ID: 15611821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin.
    Abel ED; Kaulbach HC; Campos-Barros A; Ahima RS; Boers ME; Hashimoto K; Forrest D; Wondisford FE
    J Clin Invest; 1999 Jan; 103(2):271-9. PubMed ID: 9916139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndrome of resistance to thyroid hormone: insights into thyroid hormone action.
    Kopp P; Kitajima K; Jameson JL
    Proc Soc Exp Biol Med; 1996 Jan; 211(1):49-61. PubMed ID: 8594618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.
    Pohlenz J; Weiss RE; Macchia PE; Pannain S; Lau IT; Ho H; Refetoff S
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3919-28. PubMed ID: 10566629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
    Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S
    J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to thyroid hormone.
    Safer JD; O'Connor MG; Colan SD; Srinivasan S; Tollin SR; Wondisford FE
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3099-109. PubMed ID: 10487671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to thyroid hormone.
    Chatterjee VK
    Horm Res; 1997; 48 Suppl 4():43-6. PubMed ID: 9350446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to thyroid hormone in a patient without thyroid hormone receptor mutations.
    Parikh S; Ando S; Schneider A; Skarulis MC; Sarlis NJ; Yen PM
    Thyroid; 2002 Jan; 12(1):81-6. PubMed ID: 11838736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors?
    Hayashi Y; Weiss RE; Sarne DH; Yen PM; Sunthornthepvarakul T; Marcocci C; Chin WW; Refetoff S
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3246-56. PubMed ID: 7593433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to thyroid hormone--an uncommon cause of thyroxine excess and inappropriate TSH secretion.
    Chatterjee VK
    Acta Med Austriaca; 1994; 21(2):56-60. PubMed ID: 7998483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).
    Fozzatti L; Lu C; Kim DW; Park JW; Astapova I; Gavrilova O; Willingham MC; Hollenberg AN; Cheng SY
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17462-7. PubMed ID: 21987803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor.
    Weiss RE; Hayashi Y; Nagaya T; Petty KJ; Murata Y; Tunca H; Seo H; Refetoff S
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4196-203. PubMed ID: 8954015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice bearing a human mutant thyroid hormone beta 1 receptor manifest thyroid function anomalies, weight reduction, and hyperactivity.
    Wong R; Vasilyev VV; Ting YT; Kutler DI; Willingham MC; Weintraub BD; Cheng S
    Mol Med; 1997 May; 3(5):303-14. PubMed ID: 9205946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analyses and evaluation of peripheral parameters of thyroid hormone action for the differential diagnosis of RTH. A novel heterozygous missense mutation (M334T) discovered.
    Mannavola D; Vannucchi G; Fugazzola L; Cerutti N; Persani L; Beck-Peccoz P
    J Endocrinol Invest; 2002 Feb; 25(2):RC4-6. PubMed ID: 11929097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance.
    Cheng SY
    Trends Endocrinol Metab; 2005; 16(4):176-82. PubMed ID: 15860414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
    Safer JD; Langlois MF; Cohen R; Monden T; John-Hope D; Madura J; Hollenberg AN; Wondisford FE
    Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation.
    Clifton-Bligh RJ; de Zegher F; Wagner RL; Collingwood TN; Francois I; Van Helvoirt M; Fletterick RJ; Chatterjee VK
    Mol Endocrinol; 1998 May; 12(5):609-21. PubMed ID: 9605924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel resistance to thyroid hormone associated with a new mutation (T329N) in the thyroid hormone receptor beta gene.
    Sarkissian G; Dace A; Mesmacque A; Bony-Trifunovic H; Malezet-Desmoulins C; Torresani J; Margotat A
    Thyroid; 1999 Feb; 9(2):165-71. PubMed ID: 10090317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
    Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
    Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.